Skip to content

Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis

Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07388992
Acronym
GAIT-MS
Enrollment
30
Registered
2026-02-05
Start date
2026-03-16
Completion date
2026-06-01
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult, Multiple Sclerosis

Brief summary

The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)

Interventions

None listed

Sponsors

SYSNAV
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

For people living with multiple sclerosis (pwMS): 1. Age at inclusion between =18 and =65 years old 2. Signed informed consent and ability to comply with study and follow-up. 3. Confirmed MS diagnosis according to McDonald criteria (2017) 4. Expanded Disability Status Scale EDSS = 6 5. Stable treatment for 2 months before inclusion (for both disease modifying and symptomatic therapies) 6. Ability and willingness to participate in and comply with all study procedures defined in the protocol 7. Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category For Healthy volunteers : 1. Age at inclusion between =18 and =65 years old 2. Signed informed consent and ability to comply with study and follow-up. 3. Ability and willingness to participate in and comply with all study procedures defined in the protocol 4. Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category

Exclusion criteria

For pwMS: 1. Participants with a relapse within the past 3 months before the inclusion 2. Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator 3. Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator 4. Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent. For healthy volunteers (HV): 1. Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator 2. Past or present pathology or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator 3. Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.

Design outcomes

Primary

MeasureTime frameDescription
description of ambulation pattern in controlled environment in people living with multiple sclerosis (pwMS) with different disease severitiesenrollmentMeasurement of daily life-like activity movements by Optical Motion Capture, pressure sensitive walkway and wearable sensors

Countries

France

Contacts

CONTACTFerial Toumi
ferial.toumi@sysnav.fr+33 2 78 00 10 98
PRINCIPAL_INVESTIGATORPatrick Vermersch

CHU Lille

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026